LY2608204

Inquiry

Cat. No.: DIA-0230609

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	1234703-40-2
Formula	C₂₈H₃₇N₃O₃S₃
Molecular Weight	559.81
SMILES	O=C(NC1=NC=C(SCCN2CCCC2)S1)C3(CC3C4CCCCC4)C5=CC=C(C=C5)[S](=O)(=O)C6CC6
Product Description	LY2608204 activates glucokinase (GK) with EC50 of 42 nM. Phase 2.

Format & Storage
Purity	> 98%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Top